Stockscreener 앱 받기
9.1381
1.80%
-0.2119
전일 마감가:
$9.35
열려 있는:
$9.335
하루 거래량:
3.23M
Relative Volume:
0.70
시가총액:
$1.50B
수익:
$596.34M
순이익/손실:
$-87.84M
주가수익비율:
-15.29
EPS:
-0.5975
순현금흐름:
$-97.62M
1주 성능:
-2.53%
1개월 성능:
-3.25%
6개월 성능:
+20.49%
1년 성능:
+38.90%
1일 변동 폭
$8.885
$9.48
1주일 범위
$8.885
$10.12
52주 변동 폭
$6.20
$11.97
노바백스 Stock (NVAX) Company Profile
명칭
Novavax Inc
전화
240-268-2000
주소
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
9.135 | 1.54B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
521.98 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.86 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.90 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.14 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.47 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
노바백스 Stock (NVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-08-28 | 재개 | H.C. Wainwright | Buy |
| 2025-08-20 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2025-06-17 | 개시 | Citigroup | Sell |
| 2025-02-28 | 개시 | BTIG Research | Buy |
| 2024-07-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-05-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-05-10 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-08-09 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | 재확인 | B. Riley Securities | Buy |
| 2022-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2022-12-02 | 개시 | Jefferies | Hold |
| 2022-09-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2022-02-22 | 재개 | Jefferies | Buy |
| 2022-01-21 | 개시 | Cowen | Outperform |
| 2021-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-12-14 | 개시 | Jefferies | Buy |
| 2020-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-08-05 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | 재확인 | B. Riley FBR | Buy |
| 2020-06-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-05-28 | 재확인 | B. Riley FBR | Buy |
| 2020-05-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-30 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-08-14 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-12-11 | 개시 | Oppenheimer | Outperform |
| 2018-11-26 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2018-03-29 | 업그레이드 | Seaport Global Securities | Neutral → Buy |
모두보기
노바백스 주식(NVAX)의 최신 뉴스
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance Singapore
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Does Novavax’s (NVAX) Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story? - simplywall.st
Novavax (NVAX) Stock Moves 1.36%: What You Should Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
(NVAX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 2500 Growth Benchmark - marketscreener.com
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Price to sales forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Price to sales forward of Novavax, Inc. – FWB:NVV1 - TradingView
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax boosts efficiency and productivity with ServiceNow - NTT Data
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Enterprise value to EBITDA forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Enterprise value to EBITDA forward of Novavax, Inc. – SIX:NVAX - TradingView
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Enterprise value to revenue forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Investors heavily search Novavax, Inc. (NVAX): Here is what you need to know - MSN
Enterprise value to revenue forward of Novavax, Inc. – SIX:NVAX - TradingView
Price to sales forward of Novavax, Inc. – SIX:NVAX - TradingView
Enterprise value to EBIT forward of Novavax, Inc. – SIX:NVAX - TradingView
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax, Inc. Actuals & Estimates (SIX:NVAX) - TradingView
Price to book forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
These Stocks Are Moving the Most Today: Novavax, Palantir, Shoals, Plug Power, DaVita, and More - Barron's
NVAX Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD - Moomoo
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Shah Capital campaign falls short at Novavax despite opposition to board, pay - Alternatives Watch
Shah Capital blasts Novavax annual meeting results - The American Bazaar
Novavax faces renewed attack by Shah Capital after AGM - MSN
Novavax Draws Fresh Criticism From Largest Shareholder Shah Capital Following Annual Meeting - citybiz
Novavax (NVAX) Faces Shareholder Backlash Despite AGM Resolutions Approval - GuruFocus
Novavax | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M - Moomoo
Novavax Shareholders Approve Directors, Pay and Incentive Plans - The Globe and Mail
Novavax targeted by Shah Capital after AGM (NVAX:NASDAQ) - Seeking Alpha
Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM - Yahoo Finance
Form 4 Novavax Inc For: 23 June By Investing.com - Investing.com Australia
Novavax (NVAX) director gains RSU and option grants, exercises award - Stock Titan
Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J - Moomoo
노바백스 (NVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
3.14%
자본화:
|
볼륨(24시간):